{ "kind": "framework", "value": "swimmer-plot", "collectionKey": "slides:framework:swimmer-plot:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 16, "page": 1, "pageSize": 24, "pageCount": 1, "rows": [ { "docId": "019de076-8cfe-74f8-8267-71bfaaa75a6b", "docSlug": "6f650cb16e144ff2cbcc39c10e5d03e1", "documentTitle": "23andMe | Investor Presentation Deck | 39 slides", "authorId": "23andme", "authorName": "23andMe", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "traction", "function": "show_traction", "notes": "The chart uses a swimmer plot format to visualize patient-level treatment duration, dose escalation, and response status.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of patient-level treatment duration over time", "slideHref": "/slides/019de076-8cfe-74f8-8267-71bfaaa75a6b/25", "deckHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b", "deckAnchorHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b#slide-25", "loopMatches": [ { "to": 26, "from": 23, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "222f1e4a-2305-4ee1-bc08-b05e43ea38f6", "evidence": "Slides 23-26 emphasize the importance of addressing unmet medical need in oncology", "position": 1, "objective": "Highlight the cost of inaction in addressing unmet medical need", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 39, "from": 9, "beatId": "93eec936-fceb-4bb2-ab9b-6265df978407", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution (Provide relief)", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Slides 9-39 present 23andMe's solution, including their therapeutic pipeline and approach", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-7b6a-72bb-8d98-812d56d63617", "docSlug": "f8b2787992eb3375620f74057447d0c9", "documentTitle": "Aravive | Investor Presentation Deck | 39 slides", "authorId": "aravive", "authorName": "Aravive", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "appendix_data", "function": "analyze_data", "notes": "Swimmer plot showing patient IDs on y-axis and weeks on study on x-axis, with various clinical status markers.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of patient-level longitudinal clinical trial data", "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/32", "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617", "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9434-73df-8e70-401e13bb3d65", "docSlug": "692690be0ea25b83b6a4c7490ff14999", "documentTitle": "BioAtla | Investor Presentation Deck | 55 slides", "authorId": "bioatla", "authorName": "BioAtla", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "traction", "function": "show_traction", "notes": "This is a classic swimmer plot used in oncology clinical trials to visualize time-on-treatment and response status.", "imagePath": null, "matchCount": 1, "evidence": "Standard oncology clinical trial visualization for time-on-treatment", "slideHref": "/slides/019de076-9434-73df-8e70-401e13bb3d65/35", "deckHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65", "deckAnchorHref": "/decks/019de076-9434-73df-8e70-401e13bb3d65#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de072-afcf-751b-be79-65bbe03fb0c7", "docSlug": "a4681640730b4446aa1f6ee077b8a572", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 23 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-05-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "appendix_data", "function": "analyze_data", "notes": "Standard clinical trial swimmer plot showing treatment duration, response (PR/SD), progression (PD), death, and ongoing status.", "imagePath": null, "matchCount": 1, "evidence": "Standard clinical trial visualization for patient-level longitudinal data", "slideHref": "/slides/019de072-afcf-751b-be79-65bbe03fb0c7/12", "deckHref": "/decks/019de072-afcf-751b-be79-65bbe03fb0c7", "deckAnchorHref": "/decks/019de072-afcf-751b-be79-65bbe03fb0c7#slide-12", "loopMatches": [ { "to": 23, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "623768d0-5f70-4f8f-9e81-1e86d7a34667", "evidence": "The deck presents a sense of urgency and potential benefits of investing in the company", "position": 0, "objective": "Highlight the potential consequences of not investing in Compass Therapeutics", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 12, "from": 8, "beatId": "c48aac4e-cbcc-46b6-a057-f734bc543a6f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Product", "beatSlug": "sequoia-pitch-product", "evidence": "The traction section presents clinical data for CTX-009", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de074-5234-763a-a0be-96f5f1aa05d9", "docSlug": "9279d19020d2e95032dc34a127aaa2e7", "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 40 slides", "authorId": "compass-therapeutics", "authorName": "Compass Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "appendix_data", "function": "analyze_data", "notes": "Standard clinical trial swimmer plot visualization.", "imagePath": null, "matchCount": 1, "evidence": "Standard clinical trial visualization for patient-level longitudinal data", "slideHref": "/slides/019de074-5234-763a-a0be-96f5f1aa05d9/18", "deckHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9", "deckAnchorHref": "/decks/019de074-5234-763a-a0be-96f5f1aa05d9#slide-18", "loopMatches": [ { "to": 40, "from": 3, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f0a32b3c-a238-480c-9a9d-c05166154467", "evidence": "The document implies that the current state of cancer treatment is inadequate and that innovative therapies are needed.", "position": 0, "objective": "The cost of inaction in cancer treatment", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 40, "from": 7, "name": "Pattern Hunter", "slug": "02-pattern-hunter", "bestFor": "Time-pressed audiences, building consensus, when data is strong", "matchId": "6979bcd9-f71b-4757-b297-1c4753563587", "evidence": "The document presents data and results for each of these therapies.", "position": 1, "objective": "The potential benefits of CTX-009, CTX-471, and CTX-8371", "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion", "confidence": 0.6, "description": "Group multiple pieces of evidence that together point to a pattern or conclusion" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-8778-764b-accb-e5886cb9e840", "docSlug": "a27c0c380497fe380fc0ea99c606f1fe", "documentTitle": "Equillium | Results Presentation Deck | 32 slides", "authorId": "equillium", "authorName": "Equillium", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart tracks subject progress over time (weeks) with markers for treatment milestones and clinical responses.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of longitudinal patient data over time", "slideHref": "/slides/019de073-8778-764b-accb-e5886cb9e840/27", "deckHref": "/decks/019de073-8778-764b-accb-e5886cb9e840", "deckAnchorHref": "/decks/019de073-8778-764b-accb-e5886cb9e840#slide-27", "loopMatches": [ { "to": 31, "from": 9, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "f935949f-a063-4f53-ae76-c20f25bdff22", "evidence": "The presentation implies the cost of inaction through the unmet medical need and limitations of current treatments.", "position": 0, "objective": "What is the cost of not treating Lupus Nephritis effectively?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 30, "from": 10, "name": "Jobs To Be Done", "slug": "53-jobs-to-be-done", "bestFor": "Product innovation, market entry, competitive positioning", "matchId": "5a9857ab-edc2-421f-aac9-92c4e50656db", "evidence": "The presentation discusses itolizumab's mechanism of action and efficacy in treating Lupus Nephritis.", "position": 1, "objective": "What are the jobs to be done in treating Lupus Nephritis?", "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit", "confidence": 0.6, "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying" } ], "arcBeatMatches": [ { "to": 31, "from": 10, "beatId": "74c9ceff-f718-432a-b48e-9f41e627272b", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "Itolizumab's potential solution is presented, with efficacy and safety data.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-0cc2-77db-9351-9943b4f00de7", "docSlug": "7bc984921da16d0e07defb66ba0ce0a1", "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides", "authorId": "immix-biopharma", "authorName": "Immix Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-03-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "traction", "function": "show_traction", "notes": "The chart is a swimmer plot showing patient response duration, with an annotation indicating the target population for future enrollment.", "imagePath": null, "matchCount": 1, "evidence": "Clinical trial duration of response visualization", "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/16", "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7", "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-16", "loopMatches": [ { "to": 23, "from": 16, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9e3ff9b5-ae74-4c1c-8a8b-4b20ea131916", "evidence": "Slides 16-23 present clinical trial results and market opportunity for NXC-201", "position": 1, "objective": "What are the potential benefits of NXC-201 in the market?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8183-75b8-8b2d-7503ba8c42ba", "docSlug": "f8cc3498a347f12db8c194c5955f1d44", "documentTitle": "Kymera | Investor Presentation Deck | 46 slides", "authorId": "kymera", "authorName": "Kymera Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-12-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "traction", "function": "show_traction", "notes": "The chart is a swimmer plot, a standard tool in oncology clinical trials to visualize duration of response.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of patient duration on study in oncology", "slideHref": "/slides/019de076-8183-75b8-8b2d-7503ba8c42ba/39", "deckHref": "/decks/019de076-8183-75b8-8b2d-7503ba8c42ba", "deckAnchorHref": "/decks/019de076-8183-75b8-8b2d-7503ba8c42ba#slide-39", "loopMatches": [], "arcBeatMatches": [ { "to": 46, "from": 21, "beatId": "5b777767-ae99-4f1a-ab2a-67ed14bef3b5", "arcName": "AIDA", "arcSlug": "aida", "beatName": "Action", "beatSlug": "aida-action", "evidence": "The deck concludes with a call to action, highlighting upcoming milestones and events.", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de075-60f4-719a-882e-3143e28b60e4", "docSlug": "fdbc224a3aaf8eece0f490c97a32599d", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 35 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart uses a swimmer plot format to visualize patient status (on treatment vs follow-up) and survival duration.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of patient survival duration over time", "slideHref": "/slides/019de075-60f4-719a-882e-3143e28b60e4/17", "deckHref": "/decks/019de075-60f4-719a-882e-3143e28b60e4", "deckAnchorHref": "/decks/019de075-60f4-719a-882e-3143e28b60e4#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-0505-71be-a3a1-1067f47d4f96", "docSlug": "246b804be07776f664c6b3d8600daf3e", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "Clinical trial data visualization showing patient-level outcomes over time.", "imagePath": null, "matchCount": 1, "evidence": "Standard clinical trial visualization for patient-level longitudinal data", "slideHref": "/slides/019de076-0505-71be-a3a1-1067f47d4f96/19", "deckHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96", "deckAnchorHref": "/decks/019de076-0505-71be-a3a1-1067f47d4f96#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-5473-7242-b1c4-ab6acd3f6564", "docSlug": "198a0f3704f292567efe1a435af44ee8", "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 39 slides", "authorId": "maia-biotechnology", "authorName": "MAIA Biotechnology", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "Clinical trial data visualization showing patient-level outcomes over time.", "imagePath": null, "matchCount": 1, "evidence": "Standard clinical trial visualization for patient-level longitudinal data", "slideHref": "/slides/019de076-5473-7242-b1c4-ab6acd3f6564/19", "deckHref": "/decks/019de076-5473-7242-b1c4-ab6acd3f6564", "deckAnchorHref": "/decks/019de076-5473-7242-b1c4-ab6acd3f6564#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 21, "from": 11, "beatId": "3607f1e8-344f-4fa2-80d9-afc52f26d638", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "The document presents an overview of MAIA Biotechnology's clinical trials and traction.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-b7ca-70fb-95b8-5a74e3aefffe", "docSlug": "5062b9a9257606648ea145bccd66e04d", "documentTitle": "Nuvalent | Investor Presentation Deck | 41 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The chart is a classic swimmer plot used in oncology clinical trials to visualize time-to-event data.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of individual patient treatment duration and response status over time.", "slideHref": "/slides/019de076-b7ca-70fb-95b8-5a74e3aefffe/21", "deckHref": "/decks/019de076-b7ca-70fb-95b8-5a74e3aefffe", "deckAnchorHref": "/decks/019de076-b7ca-70fb-95b8-5a74e3aefffe#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de077-19d1-772e-933a-c7f1c42d9b04", "docSlug": "d223628377f56d072b5dbf426c21baf1", "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-04-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The chart is a classic swimmer plot used in oncology clinical trials to visualize time-to-event data.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of individual patient treatment duration over time", "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/21", "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04", "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-6120-7265-9083-1f4de3ff0bf7", "docSlug": "b6cd6d5e2a349d701bc6db22946ed621", "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "The chart is a swimmer plot, commonly used in oncology to visualize time-to-event data for individual patients.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of individual patient treatment duration over time", "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/22", "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7", "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 24, "from": 13, "beatId": "8a9285c3-c673-4982-a754-e50ef65833d8", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Traction", "beatSlug": null, "evidence": "Slides 13-24: Preclinical and clinical trial results for NVL-520.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-6120-7265-9083-1f4de3ff0bf7", "docSlug": "b6cd6d5e2a349d701bc6db22946ed621", "documentTitle": "Nuvalent | Investor Presentation Deck | 52 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2023-11-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "traction", "function": "show_traction", "notes": "The chart is a swimmer plot, commonly used in oncology clinical trials to visualize time-to-event data.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of individual patient treatment duration over time", "slideHref": "/slides/019de076-6120-7265-9083-1f4de3ff0bf7/42", "deckHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7", "deckAnchorHref": "/decks/019de076-6120-7265-9083-1f4de3ff0bf7#slide-42", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de073-98a7-740c-b2bf-3eb3f25491f5", "docSlug": "adb5c4514a6016378ffb63c7d4422971", "documentTitle": "TCR2 Therapeutics | Results Presentation Deck | 34 slides", "authorId": "tcr2-therapeutics", "authorName": "TCR2 Therapeutics", "documentKindSlug": "regulatory-filing", "documentKindLabel": "Regulatory filing", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-09-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "The chart uses a swimmer plot format to track longitudinal patient data including lymphodepletion status, response type, and survival.", "imagePath": null, "matchCount": 1, "evidence": "Visual representation of longitudinal patient data in clinical trials", "slideHref": "/slides/019de073-98a7-740c-b2bf-3eb3f25491f5/19", "deckHref": "/decks/019de073-98a7-740c-b2bf-3eb3f25491f5", "deckAnchorHref": "/decks/019de073-98a7-740c-b2bf-3eb3f25491f5#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }